Biotoxtech Co., Ltd. announced financial results for the year ended December 31, 2012. For the year, the company reported revenue(sales) of KRW 17,715,967,191 against KRW 23,087,737,895 a year ago. Operating income was KRW 255,004,031 against KRW 5,091,917,809 a year ago.

Profit before tax was KRW 1,247,083,246 against KRW 3,309,917,192 a year ago. Profit attributable to owners of parent was KRW 1,351,230,555 or KRW 122 per diluted share against KRW 3,273,836,665 or KRW 336 per diluted share a year ago. Cash flows from operating activities was KRW 1,631,350,050 against KRW 3,280,152,042 a year ago.

Purchase of short term Financial Instruments was KRW 17,692,624,634 against KRW 12,888,878,672 a year ago. Purchase of buildings was KRW 56,000,000 against KRW 5,500,000 a year ago. Purchase of structure was KRW 23,000,000.

Purchase of machinery was KRW 1,034,049,034 against KRW 328,872,727 a year ago. Purchase of vehicles was KRW 22,255,530. Purchase of fixtures and fittings was KRW 103,984,463 against KRW 170,204,705 a year ago.

Purchase of Machinery was KRW 222,164,500 against KRW 646,887,273 a year ago. Purchase of construction in progress was KRW 405,808,560 against KRW 1,784,163,385 a year ago. Purchase of development costs was KRW 979,821,893 against KRW 210,280,760 a year ago.

Purchase of computer software was KRW 53,710,000 against KRW 198,780,500 a year ago. Return on equity was 5.21% against 15.06% a year ago. Return on assets was 3.02% against 7.41% a year ago.